Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Wendy S. Johnson
Age : 68
Public asset : 43,080 USD
Linked companies : MorphoSys AG - Reneo Pharmaceuticals, Inc. - Exagen Inc.
Summary 
Founder of Aires Pharmaceuticals, Inc. and Palkion, Inc., Wendy S. Johnson currently occupies the position of Managing Director at Gemini Advisors and Chief Development Officer of Reneo Pharmaceuticals, Inc. Ms. Johnson is also on the board of MorphoSys AG and Exagen, Inc.

In the past Ms. Johnson held the position of President for Palkion, Inc., Vice President-Business Development of Women First HealthCare, Inc., Vice President-Corporate Development & Operations at Selective Genetics, Inc. and Principal at Prizm Pharmaceuticals, Inc. (a subsidiary of Selective Genetics, Inc.), Manager-International Business Development at Murex Corp., Venture Partner at ProQuest Management LLC, President & Chief Executive Officer for Aires Pharmaceuticals, Inc., Director at AmpliPhi Biosciences Corp., Manager-Business Development at Synbiotics LLC, Senior Vice President-Corporate Development of Salmedix, Inc., Vice President at Mutual of New York Life, Assistant Director-Devices & Radiological Health at US Food & Drug Administration, VP-Business Development & Regulatory Affairs at Cytel Corp. and Assistant Director at Center for Devices & Radiological Health.

Ms. Johnson received an undergraduate degree from the University of Maryland, a graduate degree from Drexel University College of Medicine and an MBA from Loyola Marymount University.


Current positions of Wendy S. Johnson 
NameTitle Since
MorphoSys AG
(Biotechnology & Medical Research)
Member-Supervisory Board 2015
Reneo Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Chief Development Officer 2021
Exagen Inc.
(Healthcare Facilities & Services)
Independent Director 2020
Gemini Advisors Managing Director -


Holdings of Wendy S. Johnson 
NameEquities%Valuation
MorphoSys AG (MOR)
(Biotechnology & Medical Research)
5000.0015%28,980 USD
Exagen Inc. (XGN)
(Healthcare Facilities & Services)
1,0000.0062%14,100 USD
Reneo Pharmaceuticals, Inc. (RPHM)
(Biotechnology & Medical Research)
00.0000%0 USD


Wendy S. Johnson: Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Wendy S. Johnson : Connections